SAN DIEGO, March  06, 2026  (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Sight Sciences, Inc. (NASDAQ:SGHT). The investigation focuses on Sight Sciences executive

SGHT

Sight Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Sight Sciences facing investigation after stock price drop following revenue guidance

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>SAN DIEGO, March  06, 2026  (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Sight Sciences, Inc. (NASDAQ:SGHT). The investigation focuses on Sight Sciences executive</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Sight Sciences is under investigation by Johnson Fistel for possible securities law violations following a significant stock price decline after the company&#039;s 2026 revenue guidance. This inquiry could suggest potential legal and financial exposure for SGHT, impacting investor sentiment and stock performance in the near term.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Johnson Fistel investigates potential investor claims against Sight Sciences.</li><li>Focus is on executive actions and federal securities compliance.</li><li>Sight Sciences&#039; stock declined significantly post-revenue guidance announcement.</li><li>Financial guidance for 2026 includes $82M to $88M revenue projection.</li><li>Investors who lost money may join the investigation.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Johnson Fistel, PLLP (N/A)</strong>: Investigating SGHT regarding potential securities law violations.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>This falls under &#039;Legal&#039; as it involves an investigation regarding potential investor claims against SGHT, posing risks to the company&#039;s reputation and financial standing.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Decline in SGHT stock after fourth quarter financial disclosures raises concerns.</li><li>Ongoing investigation could lead to legal liabilities impacting financial stability.</li><li>Investor sentiment may waver, influencing stock price volatility in upcoming months.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>SGHT reported FY2025 financial results on March 4, 2026.</li><li>Projected revenue for FY2026 is $82M to $88M.</li><li>Interventional Dry Eye revenue estimated at $5M to $7M.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>SGHT may face downward pressure due to investor concerns over legal implications within the next few quarters.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>SAN DIEGO, March  06, 2026  (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Sight Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/SGHT">SGHT</a>). The investigation focuses on Sight Sciences executive officers and whether investor losses may be recovered under federal securities laws.</p>  <p><strong>What if I purchased Sight Sciences securities?</strong></p>  <p>If you purchased Sight Sciences securities and suffered losses on your investment, join our investigation now: <a href="https://www.globenewswire.com/Tracker?data=FsLHUVpdn8fQX6fXVhthMXEgmLtdkT_hqPscYmQU9fKdnTJYJxAWiN2t_Qka0J_okt1qni7kGmuhVfz3A8NTYYFFSH14yLVAnRyoN2e9zSsORzAju_lbhQY3kYK3-KwmAjYuw9Bp3er2hzK22ScfztodN286Fma_gjjGOfSvx-0=" rel="nofollow" target="_blank">Click here to join the investigation</a>.</p>  <p>Or for more information, contact Jim Baker at <a href="https://www.globenewswire.com/Tracker?data=JF3193ABav3zUCpbjaOhK2sbJ83sa5Is6imaeN_5v7WjZU6N-nq_D_wdhXgMRVYaLMxivBEqq1KB8_IPyvnK4E0q85T4jSpVLDRec7iGoXI=" rel="nofollow" target="_blank">jimb@johnsonfistel.com</a> or (619) 814-4471.</p>  <p>There is no cost or obligation to you.</p>  <p><strong>Background of the investigation</strong></p>  <p>On March 4, 2026, Sight Sciences, Inc. reported its fourth quarter and full year 2025 financial results and initiated financial guidance for fiscal year 2026. Among other things, the Company projected total revenue of approximately $82 million to $88 million, including approximately $5 million to $7 million in Interventional Dry Eye revenue, which includes revenue associated with the Company's TearCare platform.</p>  <p>Following these disclosures, Sight Sciences common stock declined significantly.</p>  <p>In light of this disclosure, Johnson Fistel is investigating whether Sight Sciences complied with the federal securities laws. If you suffered losses from your investment in Sight Sciences stock, contact Johnson Fistel.</p>  <p><strong>About Johnson Fistel, PLLP &#x7C; Securities Fraud &amp; Investor Rights</strong></p>  <p>Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit <a href="https://www.globenewswire.com/Tracker?data=ymFGiR9Gy8DQE5Hrer_hRSw_6cRnKx7MVNtYVOLh5NDnmjcBGl4Guvty43EJOOH7GycJE7kkKvH9lAd_GSwu7WFXr9Ym8gRhjGtsojk0oxA=" rel="nofollow" target="_blank"><u>www.johnsonfistel.com</u></a>.</p>  <p><strong>Achievements</strong></p>  <p>In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. This recognition reflects the firm's effectiveness in advocating for investors, having recovered approximately $90,725,000 for aggrieved clients in cases where it served as lead or co-lead counsel. This marks the eighth time the firm has been recognized as a top plaintiffs' securities law firm in the United States, based on the total dollar value of final recoveries.</p>  <p>Attorney advertising.<br></br>Past results do not guarantee future outcomes.<br></br>Services may be performed by attorneys in any of our offices.</p>  <p>Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.</p>  <p><strong>Contact</strong></p>  <p>Johnson Fistel, PLLP<br></br>501 W. Broadway, Suite 800<br></br>San Diego, CA 92101<br></br>James Baker, Investor Relations – or – Frank J. Johnson, Esq.<br></br>(619) 814-4471 &#x7C; <a href="https://www.globenewswire.com/Tracker?data=JF3193ABav3zUCpbjaOhK2sbJ83sa5Is6imaeN_5v7WMOgd9gOjR2IRnYcVHgCMOHDW2_v2h0Bng5olkwpaOqXzwXvY2fMvaZaNGyarGi3k=" rel="nofollow" target="_blank">jimb@johnsonfistel.com</a> &#x7C; <a href="https://www.globenewswire.com/Tracker?data=3V0LTAO8td2VMeghvr27Kdy9vmO8PgJfqYFSTsDottEuY4pDDwdvJjwdoHciQhbCqNqX1Cm5Qiv5WmbHVm62lq68dBBWphvMnbyCYRle2-Tq4yt3tkINehGYriPPRu_Q" rel="nofollow" target="_blank">fjohnson@johnsonfistel.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY2NzUyOCM3NDcyMjM1IzIxODE3ODk="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/ZDMwYjMxZmMtZTc5ZS00N2E3LWI5NDQtNGYxZDkwMDhjYjdkLTExOTMzNTgtMjAyNi0wMy0wNi1lbg==/tiny/Johnson-Fistel-PLLP.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c"><img src="https://ml.globenewswire.com/media/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c/small/johnson-fistel-jpg.jpg" border="0" width="150" height="150" alt="Primary Logo"></img></a></p>

Sight Sciences is under investigation by Johnson Fistel for possible securities law violations following a significant stock price decline after the company's 2026 revenue guidance. This inquiry could suggest potential legal and financial exposure for SGHT, impacting investor sentiment and stock performance in the near term.

Sight Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News